173 related articles for article (PubMed ID: 33038863)
1. Association of immune checkpoint inhibitors with respiratory infections: A review.
Hamashima R; Uchino J; Morimoto Y; Iwasaku M; Kaneko Y; Yamada T; Takayama K
Cancer Treat Rev; 2020 Nov; 90():102109. PubMed ID: 33038863
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancer.
Kehl KL; Yang S; Awad MM; Palmer N; Kohane IS; Schrag D
Cancer Immunol Immunother; 2019 Jun; 68(6):917-926. PubMed ID: 30877325
[TBL] [Abstract][Full Text] [Related]
3. A narrative review of the controversy on the risk of mycobacterial infections with immune checkpoint inhibitor use: does Goldilocks have the answer?
Vaddi A; Hulsebus HJ; O'Neill EL; Knight V; Chan ED
J Thorac Dis; 2024 Feb; 16(2):1601-1624. PubMed ID: 38505086
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and immune checkpoint inhibitors: initial considerations.
Sullivan RJ; Johnson DB; Rini BI; Neilan TG; Lovly CM; Moslehi JJ; Reynolds KL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434790
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitors and Male Fertility: Should Fertility Preservation Options Be Considered before Treatment?
Ntemou E; Delgouffe E; Goossens E
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539511
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey.
Ghosh N; Tirpack A; Chan KK; Bass AR
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33067320
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 pandemic and the population with dementia. Recommendations under the auspices of the Polish Psychiatric Association.
Łuc M; Szcześniak D; Trypka E; Mazurek J; Rymaszewska J
Psychiatr Pol; 2020 Jun; 54(3):421-436. PubMed ID: 33038878
[TBL] [Abstract][Full Text] [Related]
8. Addressing Disparities in Prenatal Care via Telehealth During COVID-19: Prenatal Satisfaction Survey in East Harlem.
Futterman I; Rosenfeld E; Toaff M; Boucher T; Golden-Espinal S; Evans K; Clare CA
Am J Perinatol; 2021 Jan; 38(1):88-92. PubMed ID: 33038898
[TBL] [Abstract][Full Text] [Related]
9. Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.
Katayama Y; Yamada T; Chihara Y; Tanaka S; Tanimura K; Okura N; Hirose K; Uda S; Shiotsu S; Hirai S; Hiranuma O; Harada T; Shimamoto T; Iwasaku M; Kaneko Y; Uchino J; Takeda T; Takayama K
Sci Rep; 2020 Oct; 10(1):17495. PubMed ID: 33060826
[TBL] [Abstract][Full Text] [Related]
10. Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non-small cell lung cancer.
Saito Y; Sasaki S; Oikado K; Tominaga J; Sata M; Sakai F; Kato T; Iwasawa T; Kenmotsu H; Kusumoto M; Baba T; Endo M; Fujiwara Y; Sugiura H; Yanagawa N; Ito Y; Sakamoto T; Ohe Y; Kuwano K
Cancer Sci; 2021 Apr; 112(4):1495-1505. PubMed ID: 33098725
[TBL] [Abstract][Full Text] [Related]
11. Diabetic Ketoacidosis as a Delayed Immune-Related Event after Discontinuation of Nivolumab.
Mae S; Kuriyama A; Tachibana H
J Emerg Med; 2021 Mar; 60(3):342-344. PubMed ID: 33097350
[TBL] [Abstract][Full Text] [Related]
12. Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis.
Sonbol MB; Riaz IB; Naqvi SAA; Almquist DR; Mina S; Almasri J; Shah S; Almader-Douglas D; Uson Junior PLS; Mahipal A; Ma WW; Jin Z; Mody K; Starr J; Borad MJ; Ahn DH; Murad MH; Bekaii-Saab T
JAMA Oncol; 2020 Dec; 6(12):e204930. PubMed ID: 33090186
[TBL] [Abstract][Full Text] [Related]
13. Effect of administering subsequent immune checkpoint inhibition in cancer patients with prior COVID-19 infection.
Bi J; Wang S; Wang Y; Yang D; Verma V; Huang J; Han G
J Infect; 2021 Mar; 82(3):414-451. PubMed ID: 33039499
[No Abstract] [Full Text] [Related]
14. Cytokine Storms in Cancer and COVID-19.
Turnquist C; Ryan BM; Horikawa I; Harris BT; Harris CC
Cancer Cell; 2020 Nov; 38(5):598-601. PubMed ID: 33038939
[TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
Theelen WSME; Chen D; Verma V; Hobbs BP; Peulen HMU; Aerts JGJV; Bahce I; Niemeijer ALN; Chang JY; de Groot PM; Nguyen QN; Comeaux NI; Simon GR; Skoulidis F; Lin SH; He K; Patel R; Heymach J; Baas P; Welsh JW
Lancet Respir Med; 2021 May; 9(5):467-475. PubMed ID: 33096027
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade.
Hu W; Wang G; Wang Y; Riese MJ; You M
iScience; 2020 Oct; 23(10):101580. PubMed ID: 33083746
[TBL] [Abstract][Full Text] [Related]
17. Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis.
Zhou T; Zhang Z; Luo F; Zhao Y; Hou X; Liu T; Wang K; Zhao H; Huang Y; Zhang L
JAMA Netw Open; 2020 Oct; 3(10):e2015748. PubMed ID: 33074323
[TBL] [Abstract][Full Text] [Related]
18. Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections.
Lei Q; Li Y; Hou HY; Wang F; Ouyang ZQ; Zhang Y; Lai DY; Banga Ndzouboukou JL; Xu ZW; Zhang B; Chen H; Xue JB; Lin XS; Zheng YX; Yao ZJ; Wang XN; Yu CZ; Jiang HW; Zhang HN; Qi H; Guo SJ; Huang SH; Sun ZY; Tao SC; Fan XL
Allergy; 2021 Feb; 76(2):551-561. PubMed ID: 33040337
[TBL] [Abstract][Full Text] [Related]
19. Impact of chemoradiotherapy on the immune-related tumour microenvironment and efficacy of anti-PD-(L)1 therapy for recurrences after chemoradiotherapy in patients with unresectable locally advanced non-small cell lung cancer.
Shirasawa M; Yoshida T; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Horinouchi H; Yamamoto N; Watanabe SI; Ohe Y; Motoi N
Eur J Cancer; 2020 Nov; 140():28-36. PubMed ID: 33039811
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma.
Arenbergerova M; Gkalpakiotis S; Arenberger P; Fialova A; Pasek M
J Dermatolog Treat; 2022 May; 33(3):1782-1783. PubMed ID: 33092421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
